LBBAP limits hospital readmissions after TAVR Posted on September 20th, 2024 by LEADconnection Post navigation Previous: FDA approves Boston Scientific leads for left bundle branch area pacingNext: Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR ATP study
FDA approves Boston Scientific leads for left bundle branch area pacing Posted on September 18th, 2024 by LEADconnection Post navigation Previous: Lumenless and Stylet-Driven Leads for Left Bundle Branch Area Pacing: Materials, Techniques, Benefits, and Trade-Offs of the Two Approaches.Next: LBBAP limits hospital readmissions after TAVR
FDA approves Biotronik lead, catheter for left bundle branch area pacing Posted on September 16th, 2024 by LEADconnection Post navigation Previous: BIOTRONIK Receives FDA Approval for LBBAP Indication on Pacing Lead and Delivery Catheter SystemNext: Cardiac implantable electronic device infection awareness – A European survey amongst implanting physicians